LIGAND Pharmaceuticals - Cls B

Name: LGND 0.75 05/15/23 Institutional Ownership (13F)
Creator: 13F Insight

0 institutions still hold LIGAND Pharmaceuticals - Cls B as of —. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.

CUSIP 53220KAF5·0 13F holders

Market cap

—

13F value held

—

visible holders

Holders

filers reporting

Concentration

—

top holder share

AI Holders Summary · —

0 institutions reported LGND 0.75 05/15/23 in —. Top-holder concentration data is loading.

No institutional holders on file yet.